NCT01096225View on ClinicalTrials.gov

Immunogenicity Study of S-OIV H1N1 Influenza Vaccine

UnknownOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

April 30, 2010

Study Completion Date

August 31, 2010

Conditions
Human Influenza
Interventions
BIOLOGICAL

split-virion, H1N1 vaccine of 15 μg

split-virion inactivated S-OIV vaccine of 15 μg on day 0 and 21.

Trial Locations (1)

100101

Institute of microbiology, Chinese Academy of Sciences, Beijing

Sponsors
All Listed Sponsors
collaborator

Hualan Biological Bacterin Co. Ltd.

INDUSTRY

collaborator

Jiangsu Province Centers for Disease Control and Prevention

NETWORK

lead

Chinese Academy of Sciences

OTHER_GOV

NCT01096225 - Immunogenicity Study of S-OIV H1N1 Influenza Vaccine | Biotech Hunter | Biotech Hunter